Atlas Trials

Safety and Tolerability Study With VY-HTT01, in Adults With Early Manifesting Huntington's Disease

Clinical trial NCT04885114 · WITHDRAWN

Trial details

NCT number
NCT04885114
Sponsor
Voyager Therapeutics
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Huntington Disease
Start date
2021-07-30
Primary completion
2024-12-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.